Purpose

A clinical trial using Effexor, a marketed anti-depressant, with the goal being promoting abstinence and decreasing depression in marijuana depenent individuals.

Type of Study: Clinical Trial
Setting of Study: outpatient
Clinical Trials.gov number: NCT00131456
Providing Clinical Treatment?: Yes
No Cost Treatment?: Yes
Care is provided in languages: English

Study Activities

Filling Out Forms
Computer Tasks
Blood Samples
Psychophysiology measurements
Provides Payment: Reimbursement for transportation
Provides Payment: Compensation for study related procedures

Eligibility

Ages Eligible for Study: 18 Years - 60 Years
Genders Eligible for Study: Both
This study is not recruiting Healthy Volunteers.

Criteria

Inclusion Criteria:
1. Currently depressed and marijuana dependent.
2. Able to give informed consent.
3. Women of child-bearing age must not me pregnant.

Location: 513 West 166th St. New York, NY 10032
Clinic: Substance Treatment and Research Services
Division: Substance Abuse

Study chairs or principal investigators:
Frances R. Levin MD, Principal Investigator

Co-investigators:
Edward Nunes,